DXR

Daxor Corporation

$8.53

-2.18%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Source: Yahoo Finance
AI summary

Price & performance

1M-14.5%
3M-13.6%
YTD-35.6%
1Y-32.0%
52-week range—
Beta0.12
Full chart and returns against a benchmark

Q-Score

44/ 100

Quality against peers; 50 is the peer median.

Growth40
Risk66
Performance50
Valuation40
Profitability36
Leverage56
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2011

Revenue$1.4M-8.4%
Net income-$7.2M-244.6%
Net margin-496.8%-811.4 pts
Historical fundamentals

Valuation

DXRIndustryP/E—49.36P/S34.433.73EV/EBITDA—23.12P/B1.383.92PEG——
Dividend yield2.12%
Every valuation metric